MLTX - Balance Sheet - MoonLake Immunotherapeutics

Current Liabilities	22.5 B
Accounts Payable	8.68 M
Short-Term Debt	1.37 M
Other Current Liabilities	22.5 B
Non-Current Liabilities	2.08 B
Long-Term Debt	1.46 M
Other Non-Current Liabilities	2.08 B

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020
ASSETS
Cash & Cash Equivalents	180.4	451.2	39.5	8.0	1.3
Short Term Investments	267.6	59.8	32.6	0	0
Receivables	2.8	1.1	0.2	0.1	0
Inventory	0	0	0	1.3	0
Other Current Assets	0	2.1	4.2	1.4	0.3
Total Current Assets	474.3	514.2	76.5	9.6	1.6
PP&E	3.6	3.9	0.3	45.7 K	0
Intangible Assets	0	0	0	0	0
Goodwill	0	0	0	0	0
Long Term Investments	0	0	0	115.0	115.0
Other Long Term Assets	0	8.4	0	(115.0)	0
Other Assets	0	0	0	0	0
Total Assets	477.9	526.5	76.8	9.7	116.6
LIABILITIES
Accounts Payable	8.7	0	47.5 K	1.2	0
Short Term Debt	1.4	1.3	0.2	15.0	58.1 K
Other Current Liabilities	22 453.2	8.3	7.4	4.8	67.1 K
Total Current Liabilities	22 463.9	10.0	7.7	21.1	0.1
Long Term Debt	1.5	2.5	0.1	0	0
Deferred Tax Income	0	0	0	0	0
Other Liabilities	2 076.8	0.6	0.3	0.2	4.0
Total Liabilities	24 542.1	13.0	8.1	21.3	4.2
EQUITY
Common Stock	6.39 K	6.3 K	5.27 K	38.5 K	115.0
Retained Earnings	(235 593.0)	(116.7)	(80.7)	(53.6)	(2.5)
Other Accumulative Comprehensive Income/Loss	5.0	2.4	0.4	(0.2)	0
Total Equity	446 831.6	513.5	68.8	(11.6)	112.5
Total Liabilities and Equity	477.9	526.5	76.8	9.7	116.6
SHARES OUTSTANDING
Common Shares Outstanding	62.9	49.1	29.4	7.8	14.8

Free